LABT · Forms 3, 4, 5
Insider trades at Lakewood-Amedex Biotherapeutics Inc.
No open-market insider buys or sells at Lakewood-Amedex Biotherapeutics Inc. in the last 90 days; 6 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Lakewood-Amedex Biotherapeutics Inc. (LABT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Lakewood-Amedex Biotherapeutics Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Joseph Edward Tucker | Director | Options or other derivatives | Form 4 | ||||
| Joseph Edward Tucker | Director | Became an insider (Form 3) | Form 3 | ||||
| Leonard James DeRoma | Director | Became an insider (Form 3) | Form 3 | ||||
| Thomas Balzer | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Kelvin Cooper | Chief Executive Officer | Became an insider (Form 3) | Form 3 | ||||
| Peter Ceccacci | Chief Financial Officer | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.